meRfi®-GM
Chronic myeloid leukemia / Chronic myelogenous leukemia (CML)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
References (Sources)
- Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
- Chronic myeloid leukaemia
- Emerging alternatives to tyrosine kinase inhibitors for treating chronic myeloid leukemia
- Exploring stem cell heterogeneity in chronic myeloid leukemia
- Front-Line Treatment Options for Chronic-Phase Chronic Myeloid Leukemia
- Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia
- Treatment for chronic myelogenous leukemia: the long road to imatinib